To hear about similar clinical trials, please enter your email below

Trial Title: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

NCT ID: NCT01373736

Condition: Pheochromocytoma
Neuroblastoma
Paraganglioma
Medullary Thyroid Carcinoma
Carcinoid Tumors

Conditions: Official terms:
Neuroblastoma
Carcinoid Tumor
Thyroid Neoplasms
Pheochromocytoma
Paraganglioma
3-Iodobenzylguanidine

Study type: Interventional

Study phase: Phase 3

Overall status: Unknown status

Study design:

Primary purpose: Diagnostic

Intervention:

Intervention type: Drug
Intervention name: 123I-meta-iodobenzylguanidine

Summary: The study is designed to study the safety and effectiveness of 123I-MIBG as a diagnostic imaging agent in evaluating patients with known or suspected neuroendocrine tumors.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Subjects must have a clinical indication for 123I-MIBG imaging to evaluate for the presence, extent, or status of neuroendocrine tumors; - subjects must be able and willing to comply with study procedures. Exclusion Criteria: - Subjects with history of renal insufficiency (serum creatinine level > 3.0 mg/dL [265 µmol/L]) and inability to be withdrawn from medications known to interfere with 123I-MIBG uptake; - Subjects unable to tolerate lying supine; - Subjects pregnant or breastfeeding, unless the information to be gained outweighs the possible hazardous effects of 123I-MIBG administration. Where the assessment of the risk/benefit ration suggests the use of 123I-MIBG in nursing mothers, the breastfeeding should be discontinued for at least 48 hours post-injection.

Gender: All

Minimum age: N/A

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Vancouver Coastal Health

Address:
City: Vancouver
Zip: V5Z1M9
Country: Canada

Lead sponsor:
Agency: Vancouver Coastal Health
Agency class: Other

Source: Vancouver Coastal Health

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT01373736

Login to your account

Did you forget your password?